Helix PartnersCardiomyopathy prevalence exceeds 30% in individuals with TTN variants and early atrial fibrillationJanuary 11, 2023
Helix PartnersWellSpan Health and Helix Announce Partnership to Improve Patient Health Outcomes Through New Population Genomics ProgramDecember 7, 2022
Health SystemsHow using genomic testing as part of routine care can advance precision medicine and health equityDecember 6, 2022
Helix PartnersAn Interview with Anthony Aquilina, DO, MBA, EVP & Chief Physician Executive, WellSpan HealthDecember 2, 2022
Helix PartnersSouth Carolina Population Genomics Program Marks First Anniversary With Surge in ParticipationNovember 22, 2022
Population GenomicsHelix, Cone Health Partner on 100K-Subject Population Genomics StudyNovember 7, 2022
Helix PartnersPower Window: a power-based sliding window method to identify the rare and novel variants underlying gene-based association signalsOctober 26, 2022
Helix PartnersIndividuals with GCK-MODY are not at increased risk for common complications associated with T2DOctober 26, 2022
Helix PartnersCombining breast cancer PRS & genes of intermediate penetrance improves risk stratification in the Healthy Nevada ProjectOctober 26, 2022
